Home/Filings/4/0001209191-23-014165
4//SEC Filing

Koneru Mythili 4

Accession 0001209191-23-014165

CIK 0001094038other

Filed

Feb 28, 7:00 PM ET

Accepted

Mar 1, 4:51 PM ET

Size

5.7 KB

Accession

0001209191-23-014165

Insider Transaction Report

Form 4
Period: 2023-02-27
Koneru Mythili
Snr VP, Clinical Development
Transactions
  • Award

    Employee Stock Option (right to buy)

    2023-02-27+51,91851,918 total
    Exercise: $2.14Exp: 2033-02-27Common Stock (51,918 underlying)
Footnotes (1)
  • [F1]This option vests in equal monthly installments over a four year period commencing on March 27, 2023 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.

Issuer

Marker Therapeutics, Inc.

CIK 0001094038

Entity typeother

Related Parties

1
  • filerCIK 0001776659

Filing Metadata

Form type
4
Filed
Feb 28, 7:00 PM ET
Accepted
Mar 1, 4:51 PM ET
Size
5.7 KB